Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$14.35 USD
+0.13 (0.91%)
Updated May 3, 2024 04:00 PM ET
After-Market: $14.34 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$14.35 USD
+0.13 (0.91%)
Updated May 3, 2024 04:00 PM ET
After-Market: $14.34 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Zacks News
Washington Prime Makes Leasing Progress a Southern Park Mall
by Zacks Equity Research
Redevelopment efforts at Southern Park Mall have likely enabled Washington Prime (WPG) to retain its existing tenants at the site and introduce new ones even in these uncertain times.
Should You Hold Ventas (VTR) Stock in Your Portfolio Now?
by Zacks Equity Research
Ventas (VTR) is focusing to capture the upside in the office segment amid higher demand for research and innovation space. Yet, choppy fundamental of the senior housing market is a spoilsport.
Sabra Healthcare (SBRA) Q2 FFO and Revenues Beat Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 12.50% and 5.24%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Sabra Healthcare (SBRA) Tops Q1 FFO Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 2.27% and -3.20%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Company News for Feb 25, 2020
by Zacks Equity Research
Companies In The News Are: SBRA, CTB, DORM, CRI.
Sabra Healthcare (SBRA) Surpasses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 4.44% and 3.52%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Sabra Healthcare (SBRA) Surpasses Q3 FFO Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 2.17% and -2.32%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Sabra (SBRA) Amends $2.2B Credit Facility, Extends Maturities
by Zacks Equity Research
Sabra Health Care (SBRA) restates unsecured credit facility aggregating $2.2 billion, which will improve its debt maturities laddering. The company has no significant expirations until 2022.
Sabra Healthcare (SBRA) Q2 FFO Miss Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of -2.13% and 35.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Sabra Healthcare (SBRA) Lags Q1 FFO and Revenue Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of -4.00% and -5.59%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Iron Mountain (IRM) to Report Q4 Earnings: What to Expect?
by Zacks Equity Research
Iron Mountain (IRM) expected to report a decline in storage rental revenues from the North American data-management segment owing to moderating volumes.
Key Factors to Impact Arbor Realty's (ABR) Q4 Earnings
by Zacks Equity Research
High levels of loan originations will support Arbor Realty's (ABR) performance in the fourth quarter. However, stiff competition in the lending market might have resulted in aggressive pricing.
What's in Store for Regency Centers (REG) in Q4 Earnings?
by Zacks Equity Research
Regency Centers (REG) will gain from premium grocery-anchored shopping centers, and focus on necessity, value, convenience and service oriented retailers will guard it from e-commerce slaughter in Q4.
Can Federal Realty (FRT) Pull Off a Surprise in Q4 Earnings?
by Zacks Equity Research
Federal Realty's (FRT) Q4 results to benefit from portfolio-repositioning efforts, upbeat consumer sales and improving absorption levels despite the choppy retail real estate environment.
What to Expect From Chimera (CIM) this Earnings Season?
by Zacks Equity Research
While Chimera Investment's (CIM) mortgage backed securities (MBS) portfolio is expected to support results, higher interest rates in Q4 will likely affect its book value.
Gaming and Leisure Properties (GLPI) Q4 Earnings Preview
by Zacks Equity Research
Gaming and Leisure Properties (GLPI) is expected to have generated stable cash flow from long-term triple-net master leases. Further, it will likely gain from strategic acquisitions.
What's in the Cards for Tanger (SKT) This Earnings Season?
by Zacks Equity Research
Despite Tanger Factory Outlet Centers' (SKT) focus on improving tenant mix, amenities and marketing programs, its Q4 results might be affected by store closures, bankruptcies and lease modifications.
Key Factors to Impact JLL's Performance This Earnings Season
by Zacks Equity Research
Jones Lang LaSalle's (JLL) Q4 results likely to reflect strength across its global regions and rising trend of outsourcing of real estate needs by companies.
CBRE Group (CBRE) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
CBRE Group (CBRE) will likely gain from improving occupier outsourcing business and strategic buyouts. Nonetheless, investors' cautious approach, trade tensions and political uncertainty remain woes.
Moving Average Crossover Alert: Sabra Healthcare
by Zacks Equity Research
Sabra Healthcare REIT, Inc. (SBRA) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Sabra Healthcare (SBRA) Misses Q3 FFO and Revenue Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of -11.29% and -6.66%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Alexandria Acquires 219 East 42nd Street, Boosts Portfolio
by Zacks Equity Research
Expanding its regional life-science cluster franchise in New York City, Alexandria Real Estate Equities (ARE) acquires a Manhattan office property through membership interest in 219/235 East LLC.
Sabra Health Care Disposes Genesis & Signature Facilities
by Zacks Equity Research
Sabra Health Care (SBRA) to use proceeds from sale of nine Genesis Healthcare facilities, and another project leased to Signature Healthcare to reduce balance under its revolving credit facility.
Aimco (AIV) to Report Q1 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Aimco's (AIV) Q1 results are likely to gain from elevated demand as a result of favorable demographics. Further, the company's diligent efforts to reposition its portfolio will help it perform better.
Host Hotels (HST) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Host Hotels & Resorts (HST) Q1 results likely to reflect benefits from its portfolio of upscale hotels across potential markets and productivity gains, and impact of high supply and tough comparisons.